Log in
Enquire now
‌

US Patent 10562934 Modulation of complement activity

Patent 10562934 was granted and assigned to Ra Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Ra Pharmaceuticals
Ra Pharmaceuticals
Current Assignee
Ra Pharmaceuticals
Ra Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10562934
Date of Patent
February 18, 2020
Patent Application Number
16554665
Date Filed
August 29, 2019
Patent Primary Examiner
‌
Jeanette M Lieb
Patent abstract

The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10562934 Modulation of complement activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.